A case report published in the New England Journal of Medicine is the first case of in-utero enzyme-replacement therapy (ERT) in a fetus with cross-reactive immunologic material (CRIM) –negative.
TIME MATTERS: Taipei Veterans General Hospital can start treatment for Pompe disease within 9.75 days, resulting in far less muscular damageBy Lin Hui-chin and Jake Chung / Staff reporter, with staff writer